prikaz prve stranice dokumenta Tumor tissue hnRNP M and HSP 90α as potential predictors of disease-specific mortality in patients with early-stage cutaneous head and neck melanoma: a proteomics-based study
  Download
PDF 2.14 MB
Scientific paper - Original scientific paper
Tumor tissue hnRNP M and HSP 90α as potential predictors of disease-specific mortality in patients with early-stage cutaneous head and neck melanoma: a proteomics-based study
Oncotarget, 10 (2019), 62; 6713-6722. https://doi.org/10.18632/oncotarget.27333
Košec, Andro; Novak, Ruđer; Konjevoda, Paško; Trkulja, Vladimir; Bedeković, Vladimir; Grgurević, Lovorka

Cite this document

Košec, A., Novak, R., Konjevoda, P., Trkulja, V., Bedeković, V. & Grgurević, L. (2019). Tumor tissue hnRNP M and HSP 90α as potential predictors of disease-specific mortality in patients with early-stage cutaneous head and neck melanoma: a proteomics-based study. Oncotarget, 10. (62), 6713-6722. doi: 10.18632/oncotarget.27333

Košec, Andro, et al. "Tumor tissue hnRNP M and HSP 90α as potential predictors of disease-specific mortality in patients with early-stage cutaneous head and neck melanoma: a proteomics-based study." Oncotarget, vol. 10, no. 62, 2019, pp. 6713-6722. https://doi.org/10.18632/oncotarget.27333

Košec, Andro, Ruđer Novak, Paško Konjevoda, Vladimir Trkulja, Vladimir Bedeković and Lovorka Grgurević. "Tumor tissue hnRNP M and HSP 90α as potential predictors of disease-specific mortality in patients with early-stage cutaneous head and neck melanoma: a proteomics-based study." Oncotarget 10, no. 62 (2019): 6713-6722. https://doi.org/10.18632/oncotarget.27333

Košec, A., et al. (2019) 'Tumor tissue hnRNP M and HSP 90α as potential predictors of disease-specific mortality in patients with early-stage cutaneous head and neck melanoma: a proteomics-based study', Oncotarget, 10(62), pp. 6713-6722. doi: 10.18632/oncotarget.27333

Košec A, Novak R, Konjevoda P, Trkulja V, Bedeković V, Grgurević L. Tumor tissue hnRNP M and HSP 90α as potential predictors of disease-specific mortality in patients with early-stage cutaneous head and neck melanoma: a proteomics-based study. Oncotarget [Internet]. 2019 November 19 [cited 2024 December 20];10(62):6713-6722. doi: 10.18632/oncotarget.27333

A. Košec, R. Novak, P. Konjevoda, V. Trkulja, V. Bedeković and L. Grgurević, "Tumor tissue hnRNP M and HSP 90α as potential predictors of disease-specific mortality in patients with early-stage cutaneous head and neck melanoma: a proteomics-based study", Oncotarget, vol. 10, no. 62, pp. 6713-6722, November 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:118329. [Accessed: 20 December 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Tumor tissue hnRNP M and HSP 90α as potential predictors of disease-specific mortality in patients with early-stage cutaneous head and neck melanoma: a proteomics-based study
AuthorAndro Košec
AuthorRuđer Novak
AuthorPaško Konjevoda
AuthorVladimir Trkulja
AuthorVladimir Bedeković
AuthorLovorka Grgurević
Author's institutionUniversity of Zagreb
School of Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
Background: Breslow tumor thickness and mitotic rate are standardly used for risk stratification of patients with malignant melanoma. However, their prognostic value is relatively limited and a need for improved prognostication has been advocated. We aimed to screen the tumor tissue proteome in a search for potentially useful prognostic factors in early-stage cutaneous head and neck melanoma. ----- Methodology and findings: Proteomic profiles of archival formalin-fixed tissue samples of 31 patients (age 23-90 years) with early-stage head and neck cutaneous malignant melanoma (American Joint Committee on Cancer, AJCC, stage I/II) were determined and expression intensities were compared to those of melanocytic nevi, yielding ratios used in data analysis. Medical charts were retrospectively reviewed to determine time elapsed since diagnosis to disease-specific death or censoring. In a multivariate recursive partitioning analysis (as per AJCC guidelines), higher expression levels of heterogeneous nuclear ribonucleoprotein M (hnRNP M) [n = 18, HR = 1.94 vs. the entire cohort; HR = 5.95 (95%CI 2.43-14.5) for "high" vs. "low" (n = 13)] and of heat shock protein 90 alpha (HSP 90α) [n = 17, HR = 2.09 vs. the entire cohort; HR = 4.59 (95%CI 1.87-11.2) for "high" vs. "low" (n = 14)] were each independently strongly associated with higher mortality (accounting for clinical and standard pathohistological features). Higher Breslow thickness and mitotic rate were associated with higher mortality only when proteomic data were disregarded. ----- Conclusions and significance: Data suggest that tumor tissue expression of hnRNP M and/or of HSP 90α deserve further investigation and clinical validation as potential novel risk stratification aids in patients with stage I-II cutaneous head and neck malignant melanoma.
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleOncotarget
Numberingvol. 10, no. 62, pp. 6713-6722
p-ISSN1949-2553
DOIhttps://doi.org/10.18632/oncotarget.27333
URN:NBNurn:nbn:hr:105:118329
Publication2019-11-19
Document URLhttps://doi.org/10.18632/oncotarget.27333
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-03-28 10:42:25